Constellation Brands Sinks Despite Solid Q3 Results

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Constellation Brands Sinks Despite Solid Q3 Results

© Matej Zukovic / iStock

When Constellation Brands Inc. (NYSE: STZ) reported its fiscal third-quarter financial results before the markets opened on Friday, the company said that it had $2.00 in earnings per share (EPS) and $1.8 billion in revenue. That compares with consensus estimates from Thomson Reuters that called for $1.89 in EPS and revenue of $1.87 billion. The same period of last year reportedly had EPS of $1.96 and $1.81 billion in revenue.

During the quarter, the board of directors approved a new $3 billion share buyback program. This is a sizable buyback considering Constellation’s market cap is only $44 billion.

Beer sales rose 8.0% in the quarter compared to last year, while wine and spirit sales fell 10.3%. The Beer segment benefited from increased sales during the Labor Day and Thanksgiving holidays. The drop in wine and spirit sales reflected the divestiture of the company’s Canadian wine business in December 2016.

In terms of guidance, the company now expects EPS for the fiscal full year to be in the range of $8.40 to $8.50. The consensus estimates call for $8.43 in EPS and $7.64 billion in revenue for the year.

[nativounit]

It’s worth pointing out that during this quarter Constellation Brands invested $190 million for a minority stake in a Canadian pot company. This is the first major foray of an alcohol brand moving into the weed industry. Specifically, Constellation Brands bought a 10% stake in Canopy Growth.

Shares of Constellation Brands pulled back about 1% to $218.45 early Friday, with a consensus analyst price target of $239.47 and a 52-week trading range of $146.40 to $229.50.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618